I stand corrected. Maybe “preclinical” wasn’t the right word. But the point still stands. There’s ongoing work across the pipeline, and a few things still in the early stages that could turn into something. At this point, it’s really about turning that progress into something shareholders can get value from, and something patients can genuinely benefit from too!!!
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
26.5¢ |
Change
-0.015(5.36%) |
Mkt cap ! $76.45M | |||
| Open | High | Low | Value | Volume |
| 28.0¢ | 28.0¢ | 26.5¢ | $350.2K | 1.294M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 35 | 590036 | 26.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 27.0¢ | 36423 | 15 |
View Market Depth
| Last trade - 13.51pm 31/07/2025 (20 minute delay) ? |
| IMU (ASX) Chart |